A Phase 1 First In Human (Fih) Study Of Amg 701, An Anti-B-Cell Maturation Antigen (Bcma) Half-Life Extended (Hle) Bite (R) (Bispecific T-Cell Engager) Molecule, In Relapsed/Refractory (Rr) Multiple Myeloma (Mm)
BLOOD（2020）
关键词
B-Cell Maturation Antigen,T cell,Multiple myeloma,Cancer research,Half-life,Chemistry,First in human,Relapsed refractory
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要